Olufunmilayo H Obisesan1, Albert D Osei1, S M Iftekhar Uddin1, Omar Dzaye2, Miguel Cainzos-Achirica3, Mohammadhassan Mirbolouk4, Olusola A Orimoloye5, Garima Sharma3, Mahmoud Al Rifai6, Andrew Stokes7, Aruni Bhatnagar8, Omar El Shahawy9, Emelia J Benjamin10, Andrew P DeFilippis8, Michael J Blaha11. 1. Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, Maryland; American Heart Association Tobacco Regulation and Addiction Center, Dallas, Texas. 2. Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, Maryland; Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland; Department of Radiology and Neuroradiology, Charité, Berlin, Germany. 3. Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, Maryland. 4. Department of Medicine, Yale New Haven Hospital, New Haven, Connecticut. 5. Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee. 6. Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas. 7. American Heart Association Tobacco Regulation and Addiction Center, Dallas, Texas; Department of Global Health, Boston University, Boston, Massachusetts. 8. American Heart Association Tobacco Regulation and Addiction Center, Dallas, Texas; Department of Medicine, University of Louisville, Louisville, Kentucky. 9. American Heart Association Tobacco Regulation and Addiction Center, Dallas, Texas; Section on Tobacco, Alcohol and Drug Use, Department of Population Health, School of Medicine, New York University, New York, New York; Public Health Research Center, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates. 10. American Heart Association Tobacco Regulation and Addiction Center, Dallas, Texas; Department of Medicine, Boston University, Boston, Massachusetts. 11. Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, Maryland; American Heart Association Tobacco Regulation and Addiction Center, Dallas, Texas. Electronic address: mblaha1@jhmi.edu.
Abstract
INTRODUCTION: The prevalence of e-cigarette use has increased dramatically in the last decade in the U.S. Understanding the prevalence, patterns of use, and risk factor associations of e-cigarette use in pregnant women is particularly important, as this could have potential health implications for the mother and the developing child. METHODS: Using Behavioral Risk Factor Surveillance System Survey data from 2016 to 2018, adult women of reproductive age (18-49 years) who reported being pregnant (n=7,434) were studied. Self-reported current e-cigarette use was the main exposure. Other measures included combustible cigarette smoking status and high-risk behaviors (including other tobacco, marijuana, or heavy alcohol use; binge drinking; and others). All analyses were done in 2019. RESULTS: Approximately 2.2% of pregnant women reported current e-cigarette use, of whom 0.6% reported daily use. The highest prevalence of e-cigarette use was observed in the youngest age group of pregnant women (3.2%), with 41.7% of all pregnant current e-cigarette users being aged 18-24 years. There was a marked increase in the prevalence of current use of e-cigarettes among pregnant women from 1.9% in 2016 to 3.8% in 2018. Approximately 46% of pregnant current e-cigarette users reported concomitant cigarette smoking. Compared with pregnant never e-cigarette users, pregnant current e-cigarette users had a higher prevalence of other tobacco product use, marijuana use, heavy alcohol intake, binge drinking, and other high-risk behaviors. CONCLUSIONS: These findings underscore the need to strengthen prevention and policy efforts, specifically in the vulnerable subgroup of pregnant women.
INTRODUCTION: The prevalence of e-cigarette use has increased dramatically in the last decade in the U.S. Understanding the prevalence, patterns of use, and risk factor associations of e-cigarette use in pregnant women is particularly important, as this could have potential health implications for the mother and the developing child. METHODS: Using Behavioral Risk Factor Surveillance System Survey data from 2016 to 2018, adult women of reproductive age (18-49 years) who reported being pregnant (n=7,434) were studied. Self-reported current e-cigarette use was the main exposure. Other measures included combustible cigarette smoking status and high-risk behaviors (including other tobacco, marijuana, or heavy alcohol use; binge drinking; and others). All analyses were done in 2019. RESULTS: Approximately 2.2% of pregnant women reported current e-cigarette use, of whom 0.6% reported daily use. The highest prevalence of e-cigarette use was observed in the youngest age group of pregnant women (3.2%), with 41.7% of all pregnant current e-cigarette users being aged 18-24 years. There was a marked increase in the prevalence of current use of e-cigarettes among pregnant women from 1.9% in 2016 to 3.8% in 2018. Approximately 46% of pregnant current e-cigarette users reported concomitant cigarette smoking. Compared with pregnant never e-cigarette users, pregnant current e-cigarette users had a higher prevalence of other tobacco product use, marijuana use, heavy alcohol intake, binge drinking, and other high-risk behaviors. CONCLUSIONS: These findings underscore the need to strengthen prevention and policy efforts, specifically in the vulnerable subgroup of pregnant women.
Authors: Andrew R Hansen; Toyin O Akomolafe; Zachary McGalliard; Laura Belle-Isle; Jian Zhang Journal: Public Health Rep Date: 2018-10-02 Impact factor: 2.792
Authors: Allison N Kurti; Ryan Redner; Janice Y Bunn; Katherine Tang; Tyler Nighbor; Alexa A Lopez; Diana R Keith; Andrea C Villanti; Cassandra A Stanton; Diann E Gaalema; Nathan J Doogan; Antonio Cepeda-Benito; Megan E Roberts; Julie Phillips; Maria A Parker; Amanda J Quisenberry; Stephen T Higgins Journal: Prev Med Date: 2018-08-23 Impact factor: 4.018
Authors: Mohammadhassan Mirbolouk; Paniz Charkhchi; Sina Kianoush; S M Iftekhar Uddin; Olusola A Orimoloye; Rana Jaber; Aruni Bhatnagar; Emelia J Benjamin; Michael E Hall; Andrew P DeFilippis; Wasim Maziak; Khurram Nasir; Michael J Blaha Journal: Ann Intern Med Date: 2018-08-28 Impact factor: 25.391
Authors: Pablo Olmedo; Walter Goessler; Stefan Tanda; Maria Grau-Perez; Stephanie Jarmul; Angela Aherrera; Rui Chen; Markus Hilpert; Joanna E Cohen; Ana Navas-Acien; Ana M Rule Journal: Environ Health Perspect Date: 2018-02-21 Impact factor: 9.031
Authors: Shawn C Chiang; Lorien C Abroms; Sean D Cleary; Ichhya Pant; Lindsay Doherty; Nandita Krishnan Journal: BMC Public Health Date: 2019-07-18 Impact factor: 3.295
Authors: Katharine Bowker; Sophie Orton; Sue Cooper; Felix Naughton; Rachel Whitemore; Sarah Lewis; Linda Bauld; Lesley Sinclair; Tim Coleman; Anne Dickinson; Michael Ussher Journal: BMC Pregnancy Childbirth Date: 2018-06-15 Impact factor: 3.007
Authors: Amanda J G Dickinson; Stephen D Turner; Stacey Wahl; Allyson E Kennedy; Brent H Wyatt; Deborah A Howton Journal: Dev Biol Date: 2021-09-17 Impact factor: 3.582
Authors: Elise E DeVito; Tessa Fagle; Alicia M Allen; Raina D Pang; Nicole Petersen; Philip H Smith; Andrea H Weinberger Journal: Curr Addict Rep Date: 2021-07-13
Authors: Sulamunn R M Coleman; Janice Y Bunn; Tyler D Nighbor; Allison N Kurti; Hypatia A Bolívar; Rachel F Tyndale; Stephen T Higgins Journal: Prev Med Date: 2021-04-27 Impact factor: 4.018